請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/21216
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林辰栖(Chen-Si Lin) | |
dc.contributor.author | I-Ming Kuo | en |
dc.contributor.author | 郭益銘 | zh_TW |
dc.date.accessioned | 2021-06-08T03:28:51Z | - |
dc.date.copyright | 2019-08-20 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-08-16 | |
dc.identifier.citation | 1. Aggarwal, B.B., Harikumar, K.B., 2009. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. The international journal of biochemistry & cell biology 41, 40-59.
2. Ammon, H.P., Wahl, M.A., 1991. Pharmacology of Curcuma longa. Planta Med 57, 1-7. 3. Andocs, G., Renner, H., Balogh, L., Fonyad, L., Jakab, C., Szasz, A., 2009a. Strong synergy of heat and modulated electromagnetic field in tumor cell killing. Strahlenther Onkol 185, 120-126. 4. Andocs, G., Szasz, O., Szasz, A., 2009b. Oncothermia treatment of cancer: from the laboratory to clinic. Electromagn Biol Med 28, 148-165. 5. Biesalski, H.K., 2007. Polyphenols and inflammation: basic interactions. Current opinion in clinical nutrition and metabolic care 10, 724-728. 6. Blanquer-Rosselló, M.d.M., Hernández-López, R., Roca, P., Oliver, J., Valle, A., 2017. Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1861, 431-440. 7. Bose, S., Panda, A.K., Mukherjee, S., Sa, G., 2015. Curcumin and tumor immune-editing: resurrecting the immune system. Cell Div 10, 6-6. 8. Brown, V.A., Patel, K.R., Viskaduraki, M., Crowell, J.A., Perloff, M., Booth, T.D., Vasilinin, G., Sen, A., Schinas, A.M., Piccirilli, G., Brown, K., Steward, W.P., Gescher, A.J., Brenner, D.E., 2010. Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis. Cancer Research 70, 9003. 9. Dhar, S., Kumar, A., Li, K., Tzivion, G., Levenson, A.S., 2015. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1853, 265-275. 10. Dicheva, B.M., Koning, G.A., 2014. Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors. Expert opinion on drug delivery 11, 83-100. 11. Dorai, T., Cao, Y.C., Dorai, B., Buttyan, R., Katz, A.E., 2001. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47, 293-303. 12. Gianfranco Baronzio, G.P., Marco Ballerini, Andras Szasz, Miriam Baronzio and Valter Cassutti, 2014. A Brief Overview of Hyperthermia in Cancer Treatment. Journal of Integrative Oncology 3, 115. 13. Hegyi, G., Szigeti, G.P., Szász, A., 2013. Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy. Evidence-based complementary and alternative medicine : eCAM 2013, 672873-672873. 14. Hildebrandt, B., Wust, P., Ahlers, O., Dieing, A., Sreenivasa, G., Kerner, T., Felix, R., Riess, H., 2002. The cellular and molecular basis of hyperthermia. Critical reviews in oncology/hematology 43, 33-56. 15. Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M.K., Arfuso, F., Kumar, A.P., Bishayee, A., Ahn, K.S., 2017. The Role of Resveratrol in Cancer Therapy. International journal of molecular sciences 18, 2589. 16. Lee, S.-Y., Kim, J.-H., Han, Y.-H., Cho, D.-H., 2018. The effect of modulated electro-hyperthermia on temperature and blood flow in human cervical carcinoma. International Journal of Hyperthermia 34, 953-960. 17. Lin, J.K., Pan, M.H., Lin-Shiau, S.Y., 2000. Recent studies on the biofunctions and biotransformations of curcumin. BioFactors (Oxford, England) 13, 153-158. 18. Momtazi, A.A., Shahabipour, F., Khatibi, S., Johnston, T.P., Pirro, M., Sahebkar, A., 2016. Curcumin as a MicroRNA Regulator in Cancer: A Review, In: Reviews of Physiology, Biochemistry and Pharmacology, Vol. 171. Springer International Publishing, Cham, pp. 1-38. 19. Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P., Aggarwal, B.B., 2001. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20, 7597-7609. 20. Narayanan, N.K., Nargi, D., Randolph, C., Narayanan, B.A., 2009. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. International Journal of Cancer 125, 1-8. 21. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.D., Woodle, M.C., Lasic, D.D., Redemann, C., et al., 1991. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A 88, 11460-11464. 22. Park, C.H., Hahm, E.R., Park, S., Kim, H.K., Yang, C.H., 2005. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling. FEBS letters 579, 2965-2971. 23. Qing Ji , X.L., Xiaoling Fu, Long Zhang, Hua Sui, Lihong Zhou, Jian Sun, Jianfeng Cai, Jianmin Qin, Jianlin Ren , Qi Li, 2013. Resveratrol Inhibits Invasion and Metastasis of Colorectal Cancer Cells via MALAT1 Mediated Wnt/β-Catenin Signal Pathway. PloS one 8. 24. Rao, W., Zhang, W., Poventud-Fuentes, I., Wang, Y., Lei, Y., Agarwal, P., Weekes, B., Li, C., Lu, X., Yu, J., He, X., 2014. Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction. Acta Biomaterialia 10, 831-842. 25. Saha, S., Adhikary, A., Bhattacharyya, P., Das, T., Sa, G., 2012. Death by design: where curcumin sensitizes drug-resistant tumours. Anticancer research 32, 2567-2584. 26. Satoskar, R.R., Shah, S.J., Shenoy, S.G., 1986. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. International journal of clinical pharmacology, therapy, and toxicology 24, 651-654. 27. Sciandra, J.J., Subjeck, J.R., 1984. Heat Shock Proteins and Protection of Proliferation and Translation in Mammalian Cells. Cancer Research 44, 5188. 28. Shao, Z.M., Shen, Z.Z., Liu, C.H., Sartippour, M.R., Go, V.L., Heber, D., Nguyen, M., 2002. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 98, 234-240. 29. Singh, C.K., Ndiaye, M.A., Ahmad, N., 2015. Resveratrol and cancer: Challenges for clinical translation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852, 1178-1185. 30. Srivastava, P.K., 1997. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens. Methods (San Diego, Calif.) 12, 165-171. 31. Stangl, S., Gross, C., Pockley, A.G., Asea, A.A., Multhoff, G., 2008. Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells. Cell Stress and Chaperones 13, 221-230. 32. Sun Young Lee, N.R.L., Dong‑Hyu Cho, Jung Soo Kim, 2017. Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation. Oncology Letters 14, 73-78. 33. Suto, R., Srivastava, P.K., 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269, 1585-1588. 34. Szasz, A., 2019. Thermal and nonthermal effects of radiofrequency on living state and applications as an adjuvant with radiation therapy. Journal of Radiation and Cancer Research 10, 1-17. 35. Szasz, A., Vincze, G., 2006. Dose concept of oncological hyperthermia: heat-equation considering the cell destruction. J Cancer Res Ther 2, 171-181. 36. Szasz, A., Vincze, G., Szasz, O., Szasz, N., 2003. An Energy Analysis of Extracellular Hyperthermia. Electromagnetic Biology and Medicine 22, 103-115. 37. Tang, J.C., Shi, H.S., Wan, L.Q., Wang, Y.S., Wei, Y.Q., 2013. Enhanced antitumor effect of curcumin liposomes with local hyperthermia in the LL/2 model. Asian Pacific journal of cancer prevention : APJCP 14, 2307-2310. 38. Tsang, Y.-W., Chi, K.-H., Huang, C.-C., Chi, M.-S., Chiang, H.-C., Yang, K.-L., Li, W.-T., Wang, Y.-S., 2019. Modulated electro-hyperthermia-enhanced liposomal drug uptake by cancer cells. Int J Nanomedicine 14, 1269-1279. 39. van der Zee, J., 2002. Heating the patient: a promising approach? Annals of Oncology 13, 1173-1184. 40. van Ginkel, P.R., Yan, M.B., Bhattacharya, S., Polans, A.S., Kenealey, J.D., 2015. Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells. Toxicology and applied pharmacology 288, 453-462. 41. Venkatadri, R., Muni, T., Iyer, A.K.V., Yakisich, J.S., Azad, N., 2016. Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death. Cell Death &Amp; Disease 7, e2104. 42. Wolter, F., Akoglu, B., Clausnitzer, A., Stein, J.r., 2001. Downregulation of the Cyclin D1/Cdk4 Complex Occurs during Resveratrol-Induced Cell Cycle Arrest in Colon Cancer Cell Lines. The Journal of Nutrition 131, 2197-2203. 43. Yang, K.L., Huang, C.C., Chi, M.S., Chiang, H.C., Wang, Y.S., Hsia, C.C., Andocs, G., Wang, H.E., Chi, K.H., 2016. In vitro comparison of conventional hyperthermia and modulated electro-hyperthermia. Oncotarget 7, 84082-84092. 44. Yoo, H.J., Lim, M.C., Seo, S.-S., Kang, S., Joo, J., Park, S.-Y., 2019. Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer. Japanese Journal of Clinical Oncology. 45. Zheng, M.E., Suhendan; Walch, Eugene T.; Tang, Chi-Hui; Grimm, Elizabeth A., 2004. Inhibition of nuclear factor-[kappa]B and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Research 3, 165-171. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/21216 | - |
dc.description.abstract | 調變電熱治療是一種腫瘤熱治療的方式,它可以透過促進熱休克蛋白的生成與釋放來活化宿主的免疫反應,引發腫瘤細胞的凋亡及壞死,同時達到破壞細胞膜完整性以增進腫瘤細胞對於化療藥的攝取。薑黃素與白藜蘆醇皆是具有抗氧化性的天然植物分子,也被證實能有效的抑制各種腫瘤的生成。然而,他們較差的生體可利用率使之在臨床治療上的效力受限,此研究嘗試以CT26結直腸癌細胞的體外與同種異體動物模式,評估調變電熱治療與薑黃素、白藜蘆醇合併使用時的抗癌能力及其機制。我們的研究結果顯示,此合併治療能夠顯著地造成CT26腫瘤細胞的凋亡、壞死及細胞週期停滯,而產生協同性的原因可能與mEHT能有效促進這兩種物質在細胞中的吸收濃度有關。小鼠活體實驗也證實此合併治療能促使CD3+T淋巴球及F4/80+巨噬細胞在腫瘤內的浸潤增加,且能有效抑制CT26癌細胞的生長。本篇的實驗結果顯示,透過mEHT本身的抗癌機制,並搭配薑黃素與白藜蘆醇本身所具有的抗氧化、提升免疫活性、抑制癌細胞生長的特點,並能更有效的達到對抗腫瘤之效果。 | zh_TW |
dc.description.abstract | Modulated electro hyperthermia (mEHT) is one of the cancer hyperthermia treatments which has been demonstrated to activate host immunity by inducing the release of heat shock proteins, triggering apoptosis and necrosis, and destroying the integrity of cell membrane to enhance cellular uptake of chemo-drugs in tumor cells. Both curcumin and resveratrol are phytochemicals function as effective antioxidants and potential inhibitors for tumor developments; however, their poor bioavailability is regarded as a major obstacle for clinical cancer treatments. This study intends to investigate if mEHT could synergistically increase the anti-cancer efficacy of combined usage of curcumin and resveratrol in CT26 in vitro and in vivo models. The preliminary results showed that curcumin combined resveratrol could produce synergistic anti-tumor effect of CT26 cells by cell cycle arrest. The further experiment indicated co-treatment of mEHT with curcumin and resveratrol significantly induced cell apoptosis and cell necrosis of CT26 cells. This triple combined therapy also efficiently inhibited the growth of CT26 tumor by inducing recruiting CD3+ T cells and F4/80+ macrophages. The results shown here have suggested a naturally compound-based, non-toxic, but effective anti-tumor strategy for clinical cancer therapies. mEHT can create a favorable tumor microenvironment for an immunological chain reaction that improves the success of combined treatments of curcumin and resveratrol. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T03:28:51Z (GMT). No. of bitstreams: 1 ntu-108-R06629024-1.pdf: 3526528 bytes, checksum: bd0d1226bc0416ec757bbf6b4dfa501c (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 致謝-I
中文摘要-II Abstract-III Chapter 1. Introduction-1 Chapter 2. Background and Literature Review-4 2.1 Modulated electro hyperthermia-4 2.2 Curcumin-5 2.3 Resveratrol-6 Chapter 3. Material and methods-8 3.1 Cell line and mice-8 3.2 Cell viability-8 3.3 Cell cycle analysis-9 3.4 in vitro Hyperthermia treatment-9 3.5 Curcumin cellular uptake assay-10 3.6 Apoptosis assay-11 3.7 Western blot-11 3.8 Animal study-12 3.9 Immunohistochemistry-14 3.10 Statistical analysis-15 Chapter 4. Results-16 4.1 Curcumin and resveratrol inhibited the cell viability in CT26 cells-16 4.2 Curcumin and resveratrol induced cell cycle arrest in CT26 cells-16 4.3 Combined curcumin and resveratrol with mEHT increased significant apoptosis in CT26 cells-18 4.4 CT26 tumor was inhibited by curcumin and resveratrol combined with mEHT treatment-19 4.5 Increasing macrophages, T lymphocytes and HSP70 expression was observed in tumor of CR + mEHT treated group by IHC-19 Chapter 5. Discussion-21 Table-25 Table 1. Sources of the antibodies used in this study for western blot and IHC staining-25 Figures-26 Fig. 1-26 Fig. 2-28 Fig. 3-30 Fig. 4-32 Fig. 5-34 Fig. 6-36 Fig. 7-38 References-39 | |
dc.language.iso | en | |
dc.title | 以調變電熱治療增強薑黃素與白藜蘆醇在結直腸癌小鼠動物模式的免疫活化能力及抗腫瘤效果 | zh_TW |
dc.title | Potential enhancement of host immunity and anti-tumor efficacy of curcumin and resveratrol by modulated electro-hyperthermia in colorectal cancer allografts | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李繼忠(Jih-Jong Li),廖泰慶(Tai-Ching Liao),蔡女滿(Nu-Man Tsai),王愈善(Yu-Shan Wang) | |
dc.subject.keyword | 調變電熱治療,薑黃素,白藜蘆醇,細胞凋亡,腫瘤微環境, | zh_TW |
dc.subject.keyword | Modulated electro hyperthermia treatment (mEHT),curcumin,resveratrol,apoptosis,tumor microenvironment, | en |
dc.relation.page | 42 | |
dc.identifier.doi | 10.6342/NTU201903910 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2019-08-17 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 獸醫學研究所 | zh_TW |
顯示於系所單位: | 獸醫學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 3.44 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。